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                                                          Abstract 
The study describes the development of gelatin based emulsion hydrogels with different 
proportions of sunflower oil. During the preparation of emulsion hydrogels, the microstructures 
of the emulsions were studied under light microscope. The hydrogels were characterized by light 
microscopy, swelling property, mucoadhesivity, pH, D.C impedance measurements and 
hemocompatibility studies. Salicylic acid was incorporated within the oil phase and its release 
behavior was studied. The microscopy of the emulsions indicated that the droplet size 
distribution becomes mono-dispersed as the proportion of the oil is increased. The microscopy of 
the emulsion hydrogels showed distorted oil droplets for all the samples. The swelling property, 
mucoadhesivity, dc impedance measurements and release rate of salicylic acid was found to 
dependent on the oil proportion. All the samples were found to have pH in the range of 6.00-7.00 
and were hemocompatible in nature indicating its probable use as controlled delivery vehicles. 
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INTRODUCTION AND OBJECTIVE                                                           
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1.1.Introduction 
Emulsions are defined as biphasic and heterogeneous systems containing two immiscible liquids 
[1-2]. One of the liquids forms the internal phase and is dispersed in the continuous liquid phase 
[3]. Depending on the polarity of the liquid phases, the emulsions may be categorized either as 
water-in-oil or oil-in-water emulsions [4].  Usually, they are thermodynamically unstable 
systems [5-6]. The emulsions may be made thermodynamically stable by using surfactants which 
help in reducing the interfacial tension amongst the two immiscible phases [7-9]. But the 
stability of the emulsions depends on the performance of the surfactant molecules.   In recent 
years, some authors have tried to improve the stability of the emulsions by immobilizing the 
internal phase by increasing the viscosity of the external phase using various polymer matrices. 
If the final texture of such an emulsion is semi-solid in nature, the emulsions are regarded as 
emulsions gels (EGs) [10-12]. If the continuous phase is polar in nature then the product is 
regarded as emulsion hydrogels (EHs) otherwise it is regarded as emulsion organogels [13-14]. 
In 1980s, EGs were used in food industry as texture modifiers [15-17]. Of late, they have been 
used to develop drug delivery vehicles. EHs have been extensively investigated to ascertain its 
properties to deliver hydrophobic drugs [18]. Various hydrophobic drugs (e.g. probucol, S-312-d 
(a potent Ca
2+
 blocker), itraconazole, griseofulvin) have been successfully incorporated within 
the EHs [19-21]. 
Gelatin, a biopolymer, is obtained from animal sources (e.g. bovine, porcine or fish collagen) 
[22]. It has been extensively used in devising various products of biomedical importance due to 
its non-toxic, non-carcinogenic, non-immunogenic and biodegradable nature [23]. It dissolves in 
water at temperatures >35 
o
C and forms a gel at temperatures ~30
 o
C, depending on the method 
of production of gelatin [24]. Since the gelatin gels have a gel-sol transition at ~30-35 
o
C, the 
cross-linking of gelatin gels have been tried to improve the stability of the products during 
handling [25-26].  
1.1. Objective of the report  
 In the present study, attempts were made to develop gelatin based EHs by altering the 
proportions of the gelatin sol and oil. The EHs were characterized thoroughly to determine its 
suitability as delivery vehicles. 
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2.1. Materials 
Gelatin and Tween 80 (polyxyethylene sorbitan monooleate) were procured from Himedia, 
Mumbai, India. Ethanol was obtained from Honyon International Inc., Hong Yang Chemical 
Corpn., China. Glutaraldehyde (25%, for synthesis; GA) and hydrocholric acid (35%pure) was 
obtained from Merck Specialities Private Limited Mumbai, India. Salicylic acid (SA) and 
sodium citrate were procured from Loba Chemie, Mumbai, India. Sunflower oil (SO) was 
obtained from local market. Goat intenstine and blood were obtained from local Butcher shop. 
Double distilled water was used throughout the study. 
  
2.2. Preparation of EHs 
Twenty grams of gelatin was dissolved in 100 ml of water, whose temperature was maintained at 
50 
o
C and kept on stirring at 400 rpm, so as to obtain a clear homogeneous sol. Subsequently, 4 
ml of tween 80 was added to the sol and the volume of the mixture was made up to 200 ml by the 
addition of warm water. This resulted in the formation of a 10 % (w/v) gelatin sol (GS). 
EHs were prepared by hot homogenizing (at 50 
o
C) GS and  SO in various proportions (GS:SO 
ratio being 2:18, 4:16, 6:14, 8:12, 10:10, 12:8, 14:6: 16:4 and 18:2) at 800 rpm for 15 min. To 
this homogenized emulsion, 1.1 ml of GA reagent (0.5 ml GA+ 0.5 ml ethanol + 0.1 ml HCl) 
was added and was further stirred for 30 sec. The mixture was then immediately poured into 
petri-dishes and was allowed to form gels. The EHs, so obtained, were washed thoroughly to 
wash off any unreacted GA and hydrochloric acid. 
The SA-loaded EHs were prepared using 1% (w/v) solution of SA in SO. Rest of the procedure 
was same. 
 
2.3. Microscopic evaluation of the hot emulsions and gels 
The microstructures of the hot emulsions were studied by under compound light microscope 
(CH20i, Olympus, India). The microscopic images of the emulsions were analyzed using ImageJ 
and NI Vision Assistant softwares. After the conversion of hot emulsions to EHs, their 
microstructures were also analyzed.  
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2.4. Swelling Behavior 
EHs were cut into 1 cm x 1 cm pieces and were weighted accurately (Wo). The pieces of the EHs 
were dipped into a beaker containing 100 ml of water. At regular intervals of time, 15 min for the 
first 1h and thereafter 30 min up to 8h, the EHs were taken out from the water, wiped and 
weighed accurately (Wt). Swelling ratio (SR) of the EHs was calculated as per the formula given 
in equation 1.  
0
0)(
W
WW
SR t


     (1) 
Where SR=swelling ratio 
Wt is the weight of the swollen gel at time. 
W0 is the initial gel weight 
 
2.5. Mucoadhesive property 
The mucoadhesive property of the samples was analyzed by modified USP disintegration method 
[27-29]. In short, intestine of freshly sacrificed goats were procured from the local butcher shop. 
The intestine was immediately transferred to cold saline solution and used within 1 h of 
collection. The intestinal lumen was cleaned thoroughly by passing saline solution 3-4 times 
through it. Thereafter, the lumen was cut open and attached to glass slides, such that the 
intestinal mucosa exposes outwards, using acrylate adhesives. EHs were cut into pieces of 1 cm 
x 1 cm and were put on the exposed surface of the mucosa. A weight of 5 g was applied over the 
EHs for 5 min. Thereafter, the vertically slides were put into USP disintegration baskets. 
Phosphate buffer (pH=7.2) was used as the disintegration medium. The experiment was carried 
out for 24 h. 
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                                             Figure 1: Tablet Disintigration apparatus 
2.6. pH Measurement 
The pH of the EHs were measured using a digital pH meter (model 132E , EI products ,India). 
The pH probe was kept in touch with the EH samples and the readings were recorded.  
 
2.7. Impedance Measurement 
DC impedance of the EHs were measured using a dc impedance meter, which was developed in-
house [30]. The impedance meter used a constant current source of 8 µA for the analysis. 
 
2.8. Hemocompatibility test 
The hemocompatibility tests were done as per the ASTM standard protocol, which figures out 
the extent of hemolysis in the presence of the samples [31-40]. For this purpose, fresh goat’s 
blood was collected in the presence of trisodium citrate (TSC) in the proportion of 3.8 g of TSC 
per 100ml to prevent the coagulation. The citrated blood was diluted with normal saline in the 
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ratio of 8:10. 0.5 ml of the diluted blood is taken in a centrifuge tube. EH samples of size 5 mm x 
5 mm is put into the tube followed by addition of 9.5 ml of saline. For positive control, 0.5 ml of 
diluted blood is mixed with 0.01 N HCl and subsequently diluted to 10 ml as HCl is having the 
ability to rupture the R.B.C. For negative control, 0.5 ml of blood is diluted to 10 ml with saline 
solution. The centrifuge tubes are incubated at 37 
o
C for 60 min. the O.D of all the solutions 
were masured at 545nm using a UV-Visible spectrophotometer. The % hemolysis is calculated 
as per the following formula: 
% 100
test Negative
positive Negative
OD OD
Hemolysis
OD OD

 

 
If the % hemolysis is <5 then the material is considered as highly hemocompatible, a value <10 
indicates hemocompatible whereas a value > 20 indicates non-hemocompatible. 
 
2.9. In vitro drug release 
SA-loaded samples were used for the study. The drug dissolution tests of the EHs were carried 
out in single basket dissolution apparatus for 5 h. EHs were cut into 5 cm x 5 cm pieces and were 
weighed accurately. The drug containing EHs were put into the dissolution basket, containing 
900 ml of water. The speed of the over-head stirrer was kept at 100 ± 5 rpm. The temperature of 
the dissolution medium was maintained at 37 ± 2
o
C. 3 ml samples were withdrawn at regular 
intervals of time, 15min for the first hour and 30 min for the remaining time, and were replaced 
with 3 ml of fresh water. The samples were analyzed at 294 nm using UV-vis spectrophotometer 
(Double Beam Spectrophotometer, model# 2303, Systronics). 
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                                           Figure 2: Dissolution Rate Test Apparatus 
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3.1. Preparation of EHs 
The various compositions of the EHs have been tabulated in table 1. G1 and G2 compositions 
failed to form gels and were not used for further analysis. The EHs had fruity and alcoholic. The 
color of the EHs varied from white for G3, where the proportion of the oil was maximum, to 
various shades of brownish-white depending on the oil proportion. Higher the proportion of the 
oil was, the whitish tinge of the samples increased. All the samples were opaque.  
 
 
 
Table 1: Composition of EHs 
 
  
Sl. No. Vol. of  gelatin sol 
(ml) 
Vol. of SO 
(ml) 
Odour Gellation property 
G1 2 18 - No gel  formed 
G2 4 16 - No gel  formed 
G3 6 14 Fruity smell Gel  formed 
G4 8 12 Fruity smell Gel  formed 
G5 10 10 Alcoholic Gel  formed 
G6 12 8 Alcoholic Gel  formed 
G7 14 6 Alcoholic Gel  formed 
G8 16 4 Alcoholic Gel  formed 
G9 18 2 Alcoholic Gel  formed 
11 
 
 
Figure 3: Emulsion hydrogel of different composition of GS and SO (a) G3 (b) G4 (c) G5 
(d) G7 (e) G8 (f) G9 
 
 
3.2. Microscopic evaluation of the emulsion and EHs 
The micrographs of the emulsions and EHs have been shown in figures 4 and 5 respectively. The 
emulsions indicated the presence of dispersed circular SO droplets within the continuous GS. 
The droplet size distribution of the oil particles indicated that as the proportion of oil was 
increased, droplet size distribution of the oil was narrow size. Figure 6 indicates the increased 
size of oil droplets as the oil proportion was decreased. Also, the particle size distribution range 
became broad, i.e. increased size distribution, as the proportion of oil decreased in the emulsions 
(figure 4). Once the emulsions were crosslinked, the oil droplets within the crosslinked structures 
lost their circularity (figure 5). 
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                                 (a)                                                                            (b) 
 
     
                               (c)                                                                        (d) 
 
      
                               (e)                                                                        (f) 
Figure 4: Light micrographs of SO-in-gelatin sol emulsion. (a) G3, (b) G4, (c) G5, (d) G7, 
(e) G8 and (f) G9. 
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                                    (a)                                                                            (b) 
    
                       (c)                                                                                             (d) 
     
                      (e)                                                                                           (f) 
Figure 5: Light micrographs of emulsion hydrogels. (a) G3, (b) G4, (c) G5, (d) G7, (e) G8 
and (f) G9. 
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Figure 6: Normalized droplet distribution pattern of SO droplets in emulsions.  
 
3.3. Swelling Behaviour 
The swelling behaviour of EHs is shown in figure 7. Swellings of the EHs were dependent on 
their oil proportions. As the proportion of oil decreased, there was a significant increase in the 
swelling ratio. This may be attributed to the higher proportions of gel fraction of gelatin present 
in the samples. It may be estimated from the swelling studies that the rate of release of the drugs 
dissolved in the oil phase may be higher for the samples with higher water content. Water 
content in the gels increases for the samples with high swelling ratio due to the increased amount 
of gelatin. This may be accounted to the partition coefficient effect, which states that the solute 
distributes itself amongst the two immiscible liquids in a definite concentration ratio [41-43]. 
The gels were able to maintain their structural integrity even after 8 h of study, though there was 
some alteration in their texture. This might facilitate the usage of the EHs as implantable delivery 
devices [44-45].  
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Figure 7:  Swelling behavior study of EHs 
 
3.4 Mucoadhesive Property 
Mucoadhesive properties of the EHs were analyzed by modified USP disintegration test method, 
which is basically an in vitro wash-off method. The time required to detach the EH samples from 
the mucosal surface was determined for 24 h. The results showed that G3, G4 and G5 samples 
got detached at 240 ± 20 min, 360 ± 25 min and 1260 ± 40 min, respectively. The other samples 
did not detach during the experimental duration. The mucoadhesion is dependent on the 
crosslinking density of the mucoadhesive polymer. As the proportion of oil increased, there was 
a subsequent decrease in the gelatin fraction. This lead to the more consumption of the –OH and 
– NH2 groups, responsible for mucoadhesion, of gelatin during the crosslinking reaction and 
hence the lower mucoadhesive property [46].  
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3.5. pH Measurement 
The pH of the biomedical products is important as these are supposed to be in contact with the 
human tissues. Any variation from the physiological pH may lead to the irritation of the cells, 
which in turn might cause immunological reactions. For this reason, US pharmacopoeia has set 
pH standards for transdermal and topical formulations [47]. The results of the EH samples have 
been tabulated in table 2. The pH of the EH samples was found to be in between 6.00-7.00, 
indicating their probable use in the formulation of the transdermal or topical products. 
 
Table 2: The pH of EHs 
Type of gels pH±SD 
G3 6.57±0.21 
G4 6.88±0.30 
G5 6.31±0.15 
G6 6.43±0.10 
G7 6.49±0.20 
G8 6.90±0.25 
G9 6.80±0.11 
 
 
3.6. Impedance Measurement 
The study indicated that the EHs were able to conduct dc electricity through the samples. The 
conductance was dependent on the oil proportions. It was found that the impedance of the EH 
samples increased linearly, with the increase in the oil fraction (figure 8). The conductance of a 
sample is dependent on the flow of ionic charges through the samples. Increase in the impedance 
indicates that the flow of these ions is hindered. It may be predicted that as the impedance of the 
gels are increasing with the increase in the oil fraction, it might result in the decrease in the drug 
release rate. 
Also, gelatin gels have been used as a matrix for iontophoretic delivery systems. Iontophoretic 
systems employ the use of electric current to improve the drug permeation in the physiological 
system. It might be possible to alter the release properties of the drugs by altering the 
composition of the EH samples. 
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Figure 8: Graph showing the impedance of EHs 
 
3.7. Hemocompatibility 
The hemocompatibility of the samples have been tabulated in table 3. The results indicate that 
the samples are highly haemocompatible in nature indicating its biocompatibility. Hence the EH 
samples may be tried as a drug delivery vehicle. 
 
                                    Table 3 Hemocompatibility test for EHs 
Sample no ODpositive ODnegative ODtest % Hemolysis 
G3 0.706 0.074 0.078 0.63% 
G5 0.706 0.074 0.086 1.9% 
G9 0.706 0.074 0.098 3.8% 
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3.8. In vitro drug release 
The release profile of SA has been shown in figure 9. The rate of release of the drug was found 
to be dependent on the composition of the EH samples. From the swelling studies and the 
impedance measurement studies, it was predicted that the rate of release of the drug will be 
lower for the samples with higher oil fraction and higher for the samples with lower oil fraction. 
The release studies confirmed the predictions of the swelling and impedance studies. The % 
release of SA varied between 80% to 40% in 5h with highest for G9 and lowest to G3, i.e. the 
rate of release was found to be higher for the samples with lower oil fraction and vice-versa. This 
can be accounted to higher diffusion rates of water into the networked structure of the samples 
with lower oil fractions and subsequent relatively quick diffusion of the drugs out of the matrix. 
Also, higher impedance of the gels with higher oil fraction hinders the diffusion of the solutes 
through the gel matrix. 
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Figure 9.  In vitro % cumulative release profile of SA from EHs 
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The release kinetics of SA from the EHs were studied by analyzing for zero order, first order and 
Higuchian models. The result of kinetics studies have been tabulated in table 4. The results 
indicated that the release of SA from EHs followed Higuchian kinetics for G3, G4, G6, G7 and 
G8 samples whereas G9 sample followed first order kinetics. This suggests that the release of the 
drug from the EHs is diffusion controlled and the EHs may be used as a matrix for controlled 
delivery.  
 
                                Table 4: Modelling of release kinetics      
Sl. No. r
2
 for model fitting Best fit 
Zero order 
model 
First order 
model 
Higuchi model 
G3 0.8317 0.8816 0.9823 Higuchi 
G4 0.8916 0.9317 0.9945 Higuchi 
G5 0.9281 0.9655 0.9951 Higuchi 
G7 0.9391 0.9783 0.9945 Higuchi 
G8         0.928 0.9773 0.9944 Higuchi 
G9 0.9741 0.9951         0.965 First order 
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Figure 10: Graphical plot indicating the Higuchian kinetics being followed by G3, G4, G6, 
G7 and G8 samples. 
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Figure 11: Graphical plot indicating the first-order release kinetics being followed by G9 
sample. 
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4.1. CONCLUSION 
The study reports the successful development of gelatin-based EHs. The study indicated that not 
only the rate of release of the drugs may be modulated but also the mucoadhesive and 
conductance properties of the gels can be altered by altering the composition of the EHs.  The 
release pattern was highly dependent on the proportion of the aqueous and hydrophobic phases. 
The gels were found to be hemocompatible and could be tried as a matrix for controlled drug 
delivery systems.   
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